Clinical trials
Recruiting Phase 1/2 Carcinoma, Transitional Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alentis Therapeutics AG | 1 |
| Arvinas Inc. | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| Daiichi Sankyo | 1 |
| Dana-Farber Cancer Institute | 1 |
| GI Innovation, Inc. | 1 |
| Inhibrx Biosciences, Inc | 1 |
| Lumara Bio Oncologics GmbH | 1 |
| Mayo Clinic | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 15 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Uterine Cervical Neoplasms | 8 |
| Carcinoma, Renal Cell | 7 |
| Melanoma | 6 |
| Squamous Cell Carcinoma of Head and Neck | 6 |
| Colorectal Neoplasms | 5 |
| Ovarian Neoplasms | 5 |
| Stomach Neoplasms | 5 |
| Endometrial Neoplasms | 4 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.